Search for: "PURDUE PHARMACEUTICAL PRODUCTS L.P." Results 1 - 20 of 35
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Feb 2017, 3:09 am by Dennis Crouch
, No. 16-296 (OxyContin patent – when is an element ‘inherently’ disclosed by the prior art for anticipation purposes) Obviousness: Purdue Pharma L.P. v. [read post]
16 Jan 2017, 5:44 pm by Dennis Crouch
, No. 16-296 (OxyContin patent – when is an element ‘inherently’ disclosed by the prior art for anticipation purposes) Obviousness: Purdue Pharma L.P. v. [read post]
14 Nov 2016, 9:16 am by Dennis Crouch
, No. 16-296 (OxyContin patent – when is an element ‘inherently’ disclosed by the prior art for anticipation purposes) Obviousness: Purdue Pharma L.P. v. [read post]
13 Oct 2016, 6:50 am by Dennis Crouch
, No. 16-296 (OxyContin patent – when is an element ‘inherently’ disclosed by the prior art for anticipation purposes) Obviousness: Purdue Pharma L.P. v. [read post]
28 Sep 2016, 8:39 am by Dennis Crouch
, No. 16-296 (OxyContin patent – when is an element ‘inherently’ disclosed by the prior art for anticipation purposes) Obviousness: Purdue Pharma L.P. v. [read post]
18 Sep 2016, 6:03 pm by Dennis Crouch
, No. 16-296 (OxyContin patent – when is an element ‘inherently’ disclosed by the prior art for anticipation purposes) Obviousness: Purdue Pharma L.P. v. [read post]
1 Feb 2016, 10:43 am by Lawrence B. Ebert
Plaintiffs-appellantsPurdue Pharma L.P., The P.F. [read post]
9 Apr 2015, 5:00 am
Medicis Pharmaceutical Corp., 342 P.3d 847 (Ariz App. 2015), once, here. [read post]
29 May 2014, 5:00 am
  In both cases they had joined medical malpractice claims against local Louisiana physicians and/or hospitals with their product liability claim against the out-of-state manufacturer.Both Arnoldand Scales were removed to federal court. [read post]
10 Nov 2013, 9:03 pm by Patent Docs
Laboratories, Inc.; Purdue Pharmaceuticals... [read post]
19 Sep 2013, 9:53 am by Bexis
The following post is exclusively the work of the Reed Smith side of the blog.Sometimes the smallest, least significant type of lawsuit can illustrate cracks in the edifice of the largest, most consequential litigation. [read post]
25 Aug 2013, 9:21 pm by Patent Docs
Purdue Pharmaceutical Products L.P. et al. v. [read post]
24 Jul 2012, 7:58 pm by FDABlog HPM
Keating as a basis for the STOPP Act is the tamper-resistant version of Purdue Pharma L.P. [read post]
15 Sep 2011, 5:00 am by Bexis
  See Meridia Products Liability Litigation v. [read post]